Anzeige
Mehr »
Login
Mittwoch, 08.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Warum der Warren Buffett des Bergbaus alles auf diese Aktie setzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
409 Leser
Artikel bewerten:
(2)

CMG Financial: CMG Announces Acquisition of Retail Division of Homebridge Financial Services

Finanznachrichten News

Acquisition brings together the retail divisions of two leading mortgage bankers to create one of the nation's top independent mortgage banking companies, together originating over $30 billion in 2022.

SAN RAMON, CA / ACCESSWIRE / March 6, 2023 / CMG Mortgage, Inc., a leading mortgage banking company that originated more than $19 billion in 2022, announced today its asset acquisition of the retail division of Homebridge Financial Services, a mortgage company based in Iselin, NJ, that originated $12 billion in the same year. This acquisition significantly increases the footprint of CMG's retail division, further solidifying its position as one of the nation's largest mortgage banks.

CMG Financial, Monday, March 6, 2023, Press release picture

"We are thrilled to add the highly successful origination team at Homebridge to our own highly successful retail team at CMG," said Christopher M. George, CEO of CMG. "From our shared heritage as privately held mortgage companies to our common focus on excellence for our customers and our employees, I am certain that together we will create meaningful opportunities for innovation and growth."

Over the last 30 years, Homebridge Financial Services has grown to become one of the largest privately held, non-bank lenders in the United States. Homebridge has more than 1,600 associates throughout the United States, more than 180 retail branches, and 2 wholesale divisions: Homebridge Wholesale and REMN Wholesale.

"CMG is a company that we have always had deep respect and admiration for," said Peter Norden, CEO of Homebridge. "Giving our retail sales team the opportunity to join forces with Chris George and his incredible team will position everyone for success in an ever-changing market," Norden said.

Homebridge will retain its wholesale division, focusing on excellence in wholesale mortgage lending. Norden will act as Executive Advisor to CMG's retail division to ensure a successful transition.

About CMG

CMG Mortgage, Inc. (NMLS #1820) is a well-capitalized mortgage banking company founded in 1993. Founder and CEO Christopher M. George was Chairman of the Mortgage Bankers Association in 2019. CMG makes its products and services available to the market through three distinct origination channels, including Retail Lending, Wholesale Lending, and Correspondent Lending. CMG currently operates in all states, including the District of Columbia, and holds approvals with FNMA, FHLMC, and GNMA. CMG is widely known throughout the mortgage banking and housing markets for responsible lending practices, industry and consumer advocacy, product innovation, and operational efficiency.

About Homebridge

Homebridge Financial Services, Inc. (NMLS #6521) is one of the largest privately held, non-bank lenders in the United States. In the last 30 years, Homebridge has grown to include approximately 1,650 Associates throughout its corporate offices, more than 180 retail branches and two wholesale divisions, Homebridge Wholesale, and REMN Wholesale. Homebridge holds FNMA, GNMA, FHLMC, FHA and VA approvals, and funded $12 billion in home loans at the close of 2022. More information on Homebridge, an Equal Opportunity Lender, can be found online at www.Homebridge.com.

Contact Information

Paul Akinmade
pakinmade@cmgfi.com

SOURCE: CMG Mortgage, Inc.

.

View source version on accesswire.com:
https://www.accesswire.com/742242/CMG-Announces-Acquisition-of-Retail-Division-of-Homebridge-Financial-Services

© 2023 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.